Prosecution Insights
Last updated: April 19, 2026

Neurodawn Pharmaceutical Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18263191 USE OF COMPOSITION CONTAINING CILOSTAZOL IN CEREBROVASCULAR DISEASES ROZOF, TIMOTHY R 1625 Non-Final OA Jul 27, 2023
18271991 APPLICATION OF CILOSTAZOL-CONTAINING COMPOSITION IN PREPARING DRUG FOR TREATING CEREBROVASCULAR DISEASE SCHMITT, MICHAEL J 1629 Non-Final OA Jul 12, 2023

Managing Neurodawn Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month